Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

1 result

  1. SOCIAL QUESTIONS|health|medical science · SOCIAL QUESTIONS|health|illness
    múcapolaisiúicríodóis de chineál 1-H Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Pfaundler-Hurler Syndrom | Lipochondrodystrophie | Mukopolysaccharidose Typ I-H | Gargoylismus | dysostotische Idiotie
    de
    Definition am Ende des 1. Lebensjahrs (u. später) sich manifestierende autosomal-rezessiv erbliche Mukopolysaccharidose mit Ablagerung von Dermatan- u. Heparansulfat in Mesenchym- u. Ganglienzellen Reference "Roche-Lexikon, http://www.gesundheit.de/roche (10.9.2008)"
    MPS I | mucopolysaccharidosis I | mucopolysaccharidosis type I-H | MPS I-H | Hurler syndrome | Hurler's syndrome | Hurler's disease | Pfaundler-Hurler syndrome | lipochondrodystrophy | dysostosis multiplex | gargoylism
    en
    Definition inherited disorder caused by a lack of specific lysosomal enzymes involved in the degradation of glycosaminoglycans (GAGs), or mucopolysaccharides, which cause interference with cell, tissue, and organ function Reference "National Center for Biotechnology Information > Hurler syndrome, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=607014 [23.5.2008]"
    Comment Children with the syndrome appear normal at birth and develop the characteristic appearance over the first years of life.
    mucopolysaccharidose de type I | MPS I | MPS I-H | maladie de Hurler | syndrome de Hurler | syndrome de Pfaundler-Hurler | lipochondrodystrophie | dysostose multiple | gargoylisme
    fr
    Comment "la mucopolysaccharidose de type 1 se subdivise en trois phénotypes : IH ou maladie de Hurler; IS ou maladie de Scheie; et IH/S ou maladie de Hurler/Scheie (voir: http://www.genzyme.ca/thera/mps/ca_fr_p_tp_thera-mps.asp [9.1.2008])"